Children born to people who had received a respiratory syncytial virus prefusion F (RSVpreF) vaccine during pregnancy were well-protected against severe disease, according to a recent trial. But the trial was stopped early due to a small but statistically significant increased risk of preterm births among pregnant people who’d received the vaccine.
